statine has been researched along with Dyslipidemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, X; Gan, X; He, S; Li, S; Li, Z; Yang, N; Zhang, L; Zheng, F | 1 |
| Ballantyne, CM; Barbalic, M; Belmont, J; Brautbar, A; Chen, F; Hegele, RA; Scherer, S; Virani, SS | 1 |
| Chevreau, M; Dougados, M; Gaudin, P; Gossec, L; Pereira, B; Soubrier, M; Tatar, Z; Tournadre, A | 1 |
3 other study(ies) available for statine and Dyslipidemia
| Article | Year |
|---|---|
Apolipoprotein E polymorphisms contribute to statin response in Chinese ASCVD patients with dyslipidemia.
Topics: Adolescent; Adult; Aged; Alleles; Amino Acids; Apolipoproteins E; Arteriosclerosis; Cardiovascular Diseases; China; Cholesterol, HDL; Dyslipidemias; Female; Genotype; Humans; Lipids; Male; Middle Aged; Rosuvastatin Calcium; Triglycerides | 2019 |
Rare APOA5 promoter variants associated with paradoxical HDL cholesterol decrease in response to fenofibric acid therapy.
Topics: Amino Acids; Apolipoprotein A-I; Apolipoprotein A-V; Apolipoproteins A; Cholesterol, HDL; Dyslipidemias; Female; Fenofibrate; Genetic Variation; Humans; Male; Promoter Regions, Genetic; Triglycerides | 2013 |
Application of the European Society of Cardiology, Adult Treatment Panel III and American College of Cardiology/American Heart Association guidelines for cardiovascular risk management in a French cohort of rheumatoid arthritis.
Topics: Adult; Aged; American Heart Association; Amino Acids; Arthritis, Rheumatoid; Cardiology; Cardiovascular Diseases; Cohort Studies; Dyslipidemias; Female; France; Humans; Male; Middle Aged; Practice Guidelines as Topic; Risk Assessment; Risk Factors; Risk Management; United States | 2015 |